Ignite Creation Date:
2025-12-24 @ 1:03 PM
Ignite Modification Date:
2026-02-20 @ 1:43 PM
Study NCT ID:
NCT02164461
Status:
COMPLETED
Last Update Posted:
2024-05-20
First Post:
2014-06-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Sponsor:
Advaxis, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03-04
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-13
First Submit QC Date:
None
Study First Post Date:
2014-06-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-02-15
Results First Submit QC Date:
None
Results First Post Date:
2024-05-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-13
Last Update Post Date:
2024-05-20
Last Update Post Date Type:
ACTUAL